Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026 Globe Newswire · Oct 23, 2026
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results Cision · Oct 23, 2026
IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine Carcinomas Cision · Oct 23, 2026
BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026 Cision · Oct 23, 2026
Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026 Cision · Oct 22, 2026
Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™ Cision · Oct 22, 2026
ZYUS Life Sciences Announces Closing of First Tranche of Non-Brokered Unit Offering Private Placement Cision · Oct 22, 2026
VVT Med Enters Panama Market Through Trial Distribution Agreement for ScleroSafe Cision · Oct 22, 2026
